Tinea corporis is a fungal skin infection having itchy red patches that affect daily life. Conventional antifungal treatments can cause resistance, while homeopathy have great result.

A comparative study on the effect of Tellurium metallicum and Juglans regia in the cases of tinea corporis. - NIL

Status

Recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/11/076850

Enrollment

Registered

2024-11-14

Start date

Unknown

Completion date

Unknown

Last updated

2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue

Interventions

Intervention1: Tellurium Metallicum: according to the susceptibility of the patients i will select the potency,30,200,1M potency BD for 15 days till 4 months Control Intervention1: Juglans Regia: acco

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age from 21 – 70 years. 2. Both sexes. 3. All socio-economic status. 4. Willing to give informed consent. 5. Recently diagnosed and pre diagnosed cases. 6. Those cases which have similar totality with Tellurium metallicum and Juglans regia.

Exclusion criteria

Exclusion criteria: 1. Age below 21 and above 70 years. 2. Patient who are unwilling to give consent to join the study. 3. Patients on topical / steroidal and systemic antifungal treatment within last 3 months. 4. Those patients with the immuno-suppressive disease or on immunosuppressive drugs. 5. Pregnant and lactating mothers. 6. Those cases which are associated with other skin diseases.

Design outcomes

Primary

Measure	Time frame
To evaluate and compare the therapeutic effect of Tellurium Metallicum and Juglans Regia in patients with tinea corporis. Timepoint: 12 months for each patient and 4 months for observation	—

Secondary

Measure	Time frame
To assess the impact of treatment with Tellurium metallicum and Juglans regia on the quality of life of patients affected by tinea corporis.Timepoint: 12 months for each patient and 4 months for observation	—

Countries

India

Contacts

Public ContactDr Sagar Naik

Parul Institute of Homoeopathy and Research, Waghodia, Vadodara (Gujarat)

babina.ningombam27545@paruluniversity.ac.in8787898567

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026